Revised SPC: Doptelet (avatrombopag maleate) 20 mg film-coated tablets

SPC updated to include license extension for treatment of primary chronic immune thrombocytopenia in adult patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins).

Source:

electronic Medicines compendium